November 23, 2015
The Department of Health and Human Services’ Friday pharmaceuticals forum assembled a broad range of participants to consider prescription drugs’ costs, effectiveness and accessibility.
November 20, 2015
A Politico Pro-Health panel on biosimilars invited straight talk from FDA Director Janet Woodcock, MD, who acknowledged the need for a safe, incremental approach to adopting biosimilar medications.
November 19, 2015
After passing the U.S. Senate and House unanimously, a bill that could help newborns exposed to opioids in their mothers’ wombs now awaits the president’s signature.
November 16, 2015
Patients living with pain increasingly face an added dimension to their condition: stigma.
November 12, 2015
Much more than simply a sticker on a medicine bottle, drug labels – or “prescribing information”—provide physicians with crucial information about medical therapies.
November 10, 2015
Prematurity Awareness Month kicked off this November with a “C” grade for the United States from the 2015 March of Dimes Premature Birth Report Card.
November 6, 2015
The Centers for Medicare and Medicaid Services has a message for state Medicaid programs: coverage policies cannot block hepatitis C patients’ access to “effective, clinically appropriate and medically necessary treatments.”
November 5, 2015
Patients battling chronic disease may find little consolation in the Department of Health and Human Services’ newly proposed rule on non-discrimination under the Affordable Care Act.
November 3, 2015
Widespread debate erupted several weeks ago when a pharmaceutical start-up bought and raised the price of a 60-year-old drug by 5,000 percent.
October 29, 2015
Recent research has yielded new clues about the early indicators of Alzheimer’s disease, raising hopes for breakthrough treatments to slow the degenerative disease.
